Effectiveness and Safety of Intermittent Preventive Treatment for Malaria Using Either Dihydroartemisinin-piperaquine or Artesunate-amodiaquine in Reducing Malaria Related Morbidities and Improving Cognitive Ability in School-aged Children in Tanzania

NCT03640403 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1555

Enrollment

OTHER_GOV

Sponsor class

Conditions

Malaria,Falciparum
Anemia

Interventions

DRUG: Dihydroartemisinin-piperaquine
DRUG: Artesunate-amodiaquine

Sponsor

National Institute for Medical Research, Tanzania

Collaborators

[object Object]